Altria's Nicotine Pouches Face FDA Hurdles
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Altrias stock dipped as FDAs fast-track program for nicotine pouches faces potential delays, causing investors to sell tobacco stocks. Altria, with its on! PLUS lines early approvals, has some room to maneuver, but regulatory pushback could reshape the nicotine market.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/ebb6b78c6fb9b65e